Xylem (XYL) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $17.3 billion.
- Xylem's Liabilities and Shareholders Equity rose 778.39% to $17.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $67.5 billion, marking a year-over-year increase of 578.1%. This contributed to the annual value of $16.5 billion for FY2024, which is 236.47% up from last year.
- As of Q3 2025, Xylem's Liabilities and Shareholders Equity stood at $17.3 billion, which was up 778.39% from $17.2 billion recorded in Q2 2025.
- Xylem's Liabilities and Shareholders Equity's 5-year high stood at $17.3 billion during Q3 2025, with a 5-year trough of $7.9 billion in Q1 2023.
- In the last 5 years, Xylem's Liabilities and Shareholders Equity had a median value of $15.8 billion in 2024 and averaged $12.5 billion.
- Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 678.43% in 2022, then soared by 10261.57% in 2023.
- Xylem's Liabilities and Shareholders Equity (Quarter) stood at $8.3 billion in 2021, then dropped by 3.91% to $8.0 billion in 2022, then skyrocketed by 102.62% to $16.1 billion in 2023, then increased by 2.36% to $16.5 billion in 2024, then increased by 4.86% to $17.3 billion in 2025.
- Its last three reported values are $17.3 billion in Q3 2025, $17.2 billion for Q2 2025, and $16.6 billion during Q1 2025.